Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 8/20 | 0.63 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.52 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.52 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | RECQL | P46063 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | FAAH | O00519 | 2/20 | 0.46 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.46 |
| ▸ | USP2 | O75604 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | BIRC2 | Q13490 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1271079 | 1.00 | GPR84 (0.63) | GPR84FFAR1FFAR4ZDHHC7L3MBTL1 | |
| SCHEMBL7599552 | 1.00 | GPR84 (0.63) | GPR84FFAR1FFAR4ZDHHC7L3MBTL1 | |
| 3-Hydroxyhexadecanoic Acid Methyl Ester SCHEMBL8177768 | 1.00 | GPR84 (0.63) | GPR84FFAR1FFAR4ZDHHC7L3MBTL1 | |
| SCHEMBL7601123 | 1.00 | GPR84 (0.63) | GPR84FFAR1FFAR4ZDHHC7L3MBTL1 | |
| 3-Hydroxyhexadecanoic Acid Methyl Ester SCHEMBL1901941 | 1.00 | GPR84 (0.63) | GPR84FFAR1FFAR4ZDHHC7L3MBTL1 | |
| SCHEMBL7599878 | 1.00 | GPR84 (0.63) | GPR84FFAR1FFAR4ZDHHC7L3MBTL1 | |
| SCHEMBL8413382 | 1.00 | GPR84 (0.63) | GPR84FFAR1FFAR4ZDHHC7L3MBTL1 | |
| SCHEMBL7606404 | 1.00 | GPR84 (0.63) | GPR84FFAR1FFAR4ZDHHC7L3MBTL1 | |
| SCHEMBL7603422 | 1.00 | GPR84 (0.63) | GPR84FFAR1FFAR4ZDHHC7L3MBTL1 | |
| SCHEMBL8780158 | 1.00 | GPR84 (0.63) | GPR84FFAR1FFAR4ZDHHC7L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210247400-A1 | ACTIVATION OF PATTERN-TRIGGERED IMMUNITY IN PLANTS BY LIPOOLIGOSACCHARID-SPECIFIC REDUCED ELICITATION (LORE) AND VARIANTS THEREOF | Technische Universität München (DE) | 2021-08-12 | — | — | US | claimed |
| EP-3790387-A1 | ACTIVATION OF PATTERN-TRIGGERED IMMUNITY IN PLANTS BY LIPOOLIGOSACCHARID-SPECIFIC REDUCED ELICITATION (LORE) AND VARIANTS THEREOF | Technische Universität München (DE) | 2021-03-17 | — | — | EP | claimed |
| WO-2019214858-A1 | ACTIVATION OF PATTERN-TRIGGERED IMMUNITY IN PLANTS BY LIPOOLIGOSACCHARID-SPECIFIC REDUCED ELICITATION (LORE) AND VARIANTS THEREOF | Technische Universität München (DE) | 2019-11-14 | — | — | WO | claimed |
| CN-121552783-A | Heat-strengthened laminated glass and preparation method thereof | 扬州鸿钜玻璃制品有限公司 | 2026-02-24 | — | — | CN | disclosed |
| US-20230416185-A1 | NEW METHODS FOR DISPROPORTIONATION QUENCHING OF OZONIDES | P2 SCIENCE, INC. | 2023-12-28 | — | — | US | disclosed |
| US-11814350-B2 | Methods for disproportionation quenching of ozonides | P2 SCIENCE, INC. (US) | 2023-11-14 | — | — | US | disclosed |
| US-20210371369-A1 | NEW METHODS FOR DISPROPORTIONATION QUENCHING OF OZONIDES | P2 SCIENCE, INC. | 2021-12-02 | — | — | US | disclosed |
| US-20210247400-A1 | ACTIVATION OF PATTERN-TRIGGERED IMMUNITY IN PLANTS BY LIPOOLIGOSACCHARID-SPECIFIC REDUCED ELICITATION (LORE) AND VARIANTS THEREOF | Technische Universität München (DE) | 2021-08-12 | — | — | US | disclosed |
| EP-3790387-A1 | ACTIVATION OF PATTERN-TRIGGERED IMMUNITY IN PLANTS BY LIPOOLIGOSACCHARID-SPECIFIC REDUCED ELICITATION (LORE) AND VARIANTS THEREOF | Technische Universität München (DE) | 2021-03-17 | — | — | EP | disclosed |
| WO-2020082007-A1 | NEW METHODS FOR DISPROPORTIONATION QUENCHING OF OZONIDES | P2 SCIENCE, INC. (US) | 2020-04-23 | — | — | WO | disclosed |
| WO-2019214858-A1 | ACTIVATION OF PATTERN-TRIGGERED IMMUNITY IN PLANTS BY LIPOOLIGOSACCHARID-SPECIFIC REDUCED ELICITATION (LORE) AND VARIANTS THEREOF | Technische Universität München (DE) | 2019-11-14 | — | — | WO | disclosed |
| EP-0856510-B1 | Optically active ceramides and process for producing the same | TAKASAGO PERFUMERY CO LTD (JP) | 2002-12-11 | — | — | EP | disclosed |
| US-5998668-A | Optically active compound and process for producing the same | TAKASAGO INTERNATIONAL CORPORATION (JP) | 1999-12-07 | — | — | US | disclosed |
| EP-0856510-A1 | Optically active ceramides and process for producing the same | Takasago International Corporation (JP) | 1998-08-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11814350-B2 | Methods for disproportionation quenching of ozonides | ALKBH3, ALKBH2, CYP11B2 | GPR84 3350/4885FFAR1 946/4885FFAR4 759/4885 |
| US-20230416185-A1 | NEW METHODS FOR DISPROPORTIONATION QUENCHING OF OZONIDES | ALKBH3, ALKBH2, NOX3 | GPR84 3433/4885FFAR1 1099/4885FFAR4 884/4885 |
| US-20210371369-A1 | NEW METHODS FOR DISPROPORTIONATION QUENCHING OF OZONIDES | ALKBH3, ALKBH2, NOX3 | GPR84 3433/4885FFAR1 1099/4885FFAR4 884/4885 |
| US-20210247400-A1 | ACTIVATION OF PATTERN-TRIGGERED IMMUNITY IN PLANTS BY LIPOOLIGOSACCHARID-SPECIFIC REDUCED ELICITATION (LORE) AND VARIANTS THEREOF | PGLS, LIPE, LYPLA2 | GPR84 2281/4885FFAR1 1534/4885FFAR4 1015/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.